Abstract
Methylmalonic aciduria and homocystinuria, cobalamin C (CblC) disease (OMIM 277400), is the most frequent inborn error of vitamin B12 (cobalamin, Cbl) metabolism and is caused by an inability of the cell to convert Cbl to its active forms (MeCbl and AdoCbl). More than 75 mutations have been identified in the MMACHC gene which is responsible for CblC disease. We present a case with CblC disease and pulmonary arterial hypertension (PAH) as the main symptom. The patient improved dramatically with parenteral hydroxocobalamin treatment. Most cases of CblC disease have a multisystemic disease with failure to thrive, developmental delay, hypotonia, visual impairment, and hematologic manifestations. This patient had isolated pulmonary hypertension and hyperhomocysteinemia which is thought to be an important factor in the pathogenesis of PAH. Genetic analysis identified a novel homozygous mutation (c.484G > T; p.Gly162Trp) in the MMACHC gene. Conclusion: CblC disease should be considered in the differential diagnosis of pulmonary hypertension.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- AdoCbl:
-
Adenosyl cobalamin
- CblC:
-
Cobalamin C
- CNCbl:
-
Cyanocobalamin
- HUS:
-
Hemolytic uremic syndrome
- MeCbl:
-
Methyl cobalamin
- MMA:
-
Methymalonic acid
- OHCbl:
-
Hydroxocobalamin
- PAH:
-
Pulmonary arterial hypertension
References
Arroliga AC, Sandur S, Jacobsen DW, Tewari S, Mustafa M, Mascha EJ, Robinson K (2003) Association between hyperhomocysteinemia and primary pulmonary hypertension. Respir Med 97:825–829
Blom HJ, Kleinveld HA, Boers GH, Demacker PN, Hak-Lemmers HL, Te Poele-Pothoff MT, Trijbels JM (1995) Lipid peroxidation and susceptibility of low-density lipoprotein to in vitro oxidation in hyperhomocysteinaemia. Eur J Clin Investig 25(3):149–154
Carrillo-Carrasco N, Chandler RJ, Venditti CP (2012) Combined methylmalonic acidemia and homocystinuria, CblC type. I. Clinical presentations, diagnosis and management. J Inherit Metab Dis 35:91–102
Hannibal L, Kim J, Brasch NE, Wang S, Rosenblatt DS, Banerjee R, Jacobsen DW (2009) Processing of alkylcobalamins in mammalian cells: a role for the MMACHC (cblC) gene product. Mol Genet Metab 97(4):260–266
Iodice FG, Chiara LD, Boenzi S, Aiello C, Monti L, Cogo P, Dionisi-Vici C (2013) Cobalamin C defect presenting with isolated pulmonary hypertension. Pediatrics 132(1):e248–e251
Kim J, Gherasim C, Banerje R (2008) Decyanation of vitamin B12 by a trafficking chaperone. Proc Natl Acad Sci U S A 105:14551–14554
Kömhoff M, Roofthooft MT, Westra D, Teertstra TK, Losito A, van de Kar NC, Berger RM (2013) Combined pulmonary hypertension and renal thrombotic microangiopathy in cobalamin C deficiency. Pediatrics 132(2):e540–e544
Lentz SR (1998) Mechanisms of thrombosis in hyperhomocysteinemia. Curr Opin Hematol 5:343–349
Lerner-Ellis JP, Tirone JC, Pawelek PD, Doré C, Atkinson JL, Watkins D, Morel CF, Fujiwara TM, Moras E, Hosack AR, Dunbar GV, Antonicka H, Forgetta V, Dobson CM, Leclerc D, Gravel RA, Shoubridge EA, Coulton JW, Lepage P, Rommens JM, Morgan K, Rosenblatt DS (2006) Identification of the gene responsible for methylmalonic aciduria and homocystinuria, CblC type. Nat Genet 38(1):93–100
Martinelli D, Deodato F, Dionisi-Vici C (2011) Cobalamin C defect: natural history, pathophysiology and treatment. J Inherit Metab Dis 34(1):127–135
Morel CF, Lerner-Ellis JR, Rosenblatt DS (2006) Combined methyl-malonic aciduria and homocystinuria (cblC): phenotype-genotype correlations and ethnic-specific observations. Mol Genet Metab 88(4):315–321
Pastore A, Martinelli D, Piemonte F, Tozzi G, Boenzi S, Di Giovamberardino G, Petrillo S, Bertini E, Dionisi-Vici C (2014) Glutathione metabolism in cobalamin deficiency type C (cblC). J Inherit Metab Dis 37(1):125–129
Profitlich LE, Kirmse B, Wasserstein MP, Diaz GA, Srivastava S (2009) High prevalence of structural heart disease in children with cblC-type methylmalonic aciduria and homocystinuria. Mol Genet Metab 98(4):344–348
Sharma AP, Greenberg CR, Prasad AN, Prasad C (2007) Hemolytic uremic syndrome (HUS) secondary to cobalamin C (cblC) disorder. Pediatr Nephrol 22(12):2097–2103
Stamler JS, Osborne JA, Jaraki O, Rabbani LE, Mullins M, Singel D, Loscalzo J (1993) Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Investig 91(1):308–318
Tanpaiboon P, Sloan JL, Callahan PF, McAreavey D, Hart PS, Lichter-Konecki U, Zand D, Venditti CP (2013) Noncompaction of the ventricular myocardium and hydrops fetalis in cobalamin C disease. JIMD Rep 10:33–38
Zighetti ML, Cattaneo M, Falcon CR, Lombardi R, Harari S, Savoritto S, Mannucci PM (1997) Absence of hyperhomocysteinemia in ten patients with primary pulmonary hypertension. Thromb Res 85(3):279–282
Conflict of interest
Dr. Gündüz, Dr. Ekici, Dr. Özaydın, Dr. Ceylaner, and Dr. Perez declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by Beat Steinmann
Rights and permissions
About this article
Cite this article
Gündüz, M., Ekici, F., Özaydın, E. et al. Reversible pulmonary arterial hypertension in cobalamin-dependent cobalamin C disease due to a novel mutation in the MMACHC gene. Eur J Pediatr 173, 1707–1710 (2014). https://doi.org/10.1007/s00431-014-2330-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00431-014-2330-6